Although PSAH is usually well tolerated by healthy subjects, as patients only complain of nausea, vomiting, and lightheadedness, it may significantly impact patients with preexisting cardiovascular risk factors (
10). The ability to predict which patients are at high risk of severe hypotension should enable anesthetists to prepare and individualize treatment for such cases (
11).
PSAH was encountered in 26 of the cases (47.27% incidence). Another study reported a high incidence, as PSAH was detected in 23 out of 40 included cases (57.5%) (
4). A previous report stated that the incidence of PSAH hypotension varied between 7.4 and 74.1% in different series (
11). The main reason for this discrepancy lies in the difference in the definition of hypotension between studies.
The subjects were classified into two categories based on PSAH prevalence: (1) with PSAH, and (2) without PSAH. By and large, no significant variation in demographic factors was seen between patients in the two groups, which should eliminate any bias that may have skewed the results in favor of one group over the other.
The results revealed that cases with PSAH had significantly higher IVCCI than those without PSAH (38.27 vs. 23.97%, respectively - P < 0.001). IVCCI had sensitivity and specificity of 84.6 and 93.1%, respectively, using a cut-off value of 33%.
In another research, the sensitivity and specificity of IVCCI with wedge in predicting hypotension in pregnant women were 60.9 and 35.5%, respectively, when using a cut-off value of 25.64%. Sensitivity and specificity for IVCCI without wedge were 69.6 and 23.5% when a cut-off value of 20.4% was used (
4). Zhang and Critchley reported that IVCCI had 50 and 31% mean values in cases with and without hypotension, respectively. They estimated the optimal cut-off value to be 43%, which had sensitivity and specificity of 78.6 and 91.7% in predicting hypotension, respectively (
12).
IVCCI is a straightforward and accurate predictor of fluid receptivity in both normal and mechanically ventilated patients, according to many studies (
13-
17). In a previous randomized controlled trial, IVCCI guided fluid therapy was associated with a 35% reduction in the incidence of PSAH (
18).
In the present study, cases with PSAH had significantly higher IJVCI than those without PSAH P < 0.001). IJVCI had mean values of 46.5 and 33.41% in both groups, respectively. With a cut-off value of 38.5%, IJVCI had sensitivity and specificity of 84.6 and 82.8%, respectively, in predicting PSAH.
Similarly, Killu et al. reported that IJVCI more than 39% had sensitivity and specificity of 87.5 and 100%, respectively, in predicting hypovolemia in critically ill patients (
19). Moreover, Haliloğlu et al. reported that IJVCI more than 36% had sensitivity and specificity of 78 and 85% respectively, in predicting hypovolemia (
20). On the other hand, some authors reported a lower cut-off value (11.4%) for IJV to predict hypovolemia, with sensitivity and specificity of 83 and 94%, respectively (
21). The discrepancy between cut-off values in different studies can be attributed to different populations, radiological experiences, or statistical tests used in them.
Unluer and Kara reported that IJVCI was a useful marker in predicting hypovolemia. It had median values of 32.74 and 38.88% before and after blood donation, respectively. Blood donation results in hypovolemia, which is reflected in IJV collapsibility (
22).
Our results showed that both IVCCI and IJVCI could be used as reliable markers to predict PSAH occurrence, with a slight superiority for IVCCI (AUC = 0.950 and 0.898 for IVC and IJV, respectively). In line with our results, Brolio and his associates reported that IVC diameter changes were a marker for fluid responsiveness. Furthermore, Prekker et al. found a good relationship between the maximum IVC diameter and the internal jugular aspect ratio (
23). Therefore, if one technique is reliable, the other will also be dependable.
Either technique is recommended to evaluate patients for whom hypotension would form a potential risk. Anesthesiologist experience in ultrasonography will play a role in setting the preferred technique together with center policy and patient characteristics. For instance, IVCCI would be harder to assess in obese individuals or cases with excess intraabdominal gases (
9), and it would be easier for anesthesiologists to calculate IJVCI. Junior anesthesiologists should start learning IVC as they are more familiar with this anatomical area and the sonographic view based on their everyday experience in ultrasound-guided central catheter installation. IJV should provide an additional advantage as it requires less image acquisition time than IVC, as reported by previous authors (
20).
Our study had a number of limitations. First, it was a single-center study that included a relatively small sample size. Therefore, more studies, including more cases, should be conducted in the future. Second, those with sensory blocks higher than T4 were excluded from the study.
5.1. Conclusion
IVCCI and IJVCI are efficacious and reliable tools in predicting PSAH in pregnant ladies undergoing cesarean section, with a slight superiority for IVCCI regarding specificity and accuracy. A greater collapsibility index leads to a lower volume status.